# DECOR Information for Project: HL7 Italia specifiche per l’implementazione (hl7itig-)
Release V1.0 as of 2026‑09‑04 11:05:21 | | | HTML built on 2026‑09‑04 11:20:13

- Front Page
- Project Information
- Dataset
- Scenarios
- Identifiers
- Terminology
- Templates
- Issues
- Compile Time
- Legal

## Identifiers

As for now used for rendering purposes only.

### ISO 3166 Part 1 Country Codes 1.0.3166.1

Language | Display Name | Description
--- | --- | ---
it-IT | ISO 3166 Part 1 Country Codes | ISO 3166 Part 1 Country Codes

### ObservationIntoleranceType 2.16.840.1.113883.1.11.19700

Language | Display Name | Description
--- | --- | ---
it-IT | ObservationIntoleranceType | ObservationIntoleranceType

### hl7ips-valueset-15 2.16.840.1.113883.11.22.15

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-15 | hl7ips-valueset-15

### hl7ips-valueset-17 2.16.840.1.113883.11.22.17

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-17 | hl7ips-valueset-17

### hl7ips-valueset-36 2.16.840.1.113883.11.22.36

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-36 | hl7ips-valueset-36

### hl7ips-valueset-9 2.16.840.1.113883.11.22.9

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-9 | hl7ips-valueset-9

### TNM Edition8 UICC 2.16.840.1.113883.15.16

Language | Display Name | Description
--- | --- | ---
it-IT | TNM Edition8 UICC | TNM Edition8 UICC

### hl7itig-valueset-16 2.16.840.1.113883.3.1937.777.63.11.16

Language | Display Name | Description
--- | --- | ---
it-IT | hl7itig-valueset-16 | hl7itig-valueset-16

### hl7itig-valueset-25 2.16.840.1.113883.3.1937.777.63.11.25

Language | Display Name | Description
--- | --- | ---
it-IT | hl7itig-valueset-25 | hl7itig-valueset-25

### hl7itig-valueset-26 2.16.840.1.113883.3.1937.777.63.11.26

Language | Display Name | Description
--- | --- | ---
it-IT | hl7itig-valueset-26 | hl7itig-valueset-26

### Tipo struttura 2.16.840.1.113883.3.1937.777.63.5.1

Language | Display Name | Description
--- | --- | ---
it-IT | Tipo struttura | Tipo struttura

### AdministrativeGender 2.16.840.1.113883.5.1

Language | Display Name | Description
--- | --- | ---
it-IT | AdministrativeGender | AdministrativeGender

### ActMood 2.16.840.1.113883.5.1001

Language | Display Name | Description
--- | --- | ---
it-IT | ActMood | ActMood

### HL7ActRelationshipType 2.16.840.1.113883.5.1002

Language | Display Name | Description
--- | --- | ---
it-IT | HL7ActRelationshipType | HL7ActRelationshipType

### Act Site 2.16.840.1.113883.5.1052

Language | Display Name | Description
--- | --- | ---
it-IT | Act Site | Act Site

### Entity Code 2.16.840.1.113883.5.1060

Language | Display Name | Description
--- | --- | ---
it-IT | Entity Code | Entity Code

### Participation Mode 2.16.840.1.113883.5.1064

Language | Display Name | Description
--- | --- | ---
it-IT | Participation Mode | Participation Mode

### RoleStatus 2.16.840.1.113883.5.1068

Language | Display Name | Description
--- | --- | ---
it-IT | RoleStatus | RoleStatus

### RoleClass 2.16.840.1.113883.5.110

Language | Display Name | Description
--- | --- | ---
it-IT | RoleClass | RoleClass

### RoleCode 2.16.840.1.113883.5.111

Language | Display Name | Description
--- | --- | ---
it-IT | RoleCode | RoleCode

### AddressUse 2.16.840.1.113883.5.1119

Language | Display Name | Description
--- | --- | ---
it-IT | AddressUse | AddressUse

### Route Of Administration 2.16.840.1.113883.5.112

Language | Display Name | Description
--- | --- | ---
it-IT | Route Of Administration | Route Of Administration

### SpecimenType 2.16.840.1.113883.5.129

Language | Display Name | Description
--- | --- | ---
it-IT | SpecimenType | SpecimenType

### TargetAwareness 2.16.840.1.113883.5.137

Language | Display Name | Description
--- | --- | ---
it-IT | TargetAwareness | TargetAwareness

### ActStatus 2.16.840.1.113883.5.14

Language | Display Name | Description
--- | --- | ---
it-IT | ActStatus | ActStatus

### Confidentiality 2.16.840.1.113883.5.25

Language | Display Name | Description
--- | --- | ---
it-IT | Confidentiality | Confidentiality

### Act Code 2.16.840.1.113883.5.4

Language | Display Name | Description
--- | --- | ---
it-IT | Act Code | Act Code

### HL7ActClass 2.16.840.1.113883.5.6

Language | Display Name | Description
--- | --- | ---
it-IT | HL7ActClass | HL7ActClass

### ActPriority 2.16.840.1.113883.5.7

Language | Display Name | Description
--- | --- | ---
it-IT | ActPriority | ActPriority

### Observation Interpretation 2.16.840.1.113883.5.83

Language | Display Name | Description
--- | --- | ---
it-IT | Observation Interpretation | Observation Interpretation

### Observation Method 2.16.840.1.113883.5.84

Language | Display Name | Description
--- | --- | ---
it-IT | Observation Method | Observation Method

### orderableDrugForm 2.16.840.1.113883.5.85

Language | Display Name | Description
--- | --- | ---
it-IT | orderableDrugForm | orderableDrugForm

### ParticipationFunction 2.16.840.1.113883.5.88

Language | Display Name | Description
--- | --- | ---
it-IT | ParticipationFunction | ParticipationFunction

### ParticipationType 2.16.840.1.113883.5.90

Language | Display Name | Description
--- | --- | ---
it-IT | ParticipationType | ParticipationType

### LOINC 2.16.840.1.113883.6.1

Language | Display Name | Description
--- | --- | ---
it-IT | LOINC | LOINC

### ICD-9-CM 2.16.840.1.113883.6.103

Language | Display Name | Description
--- | --- | ---
it-IT | ICD-9-CM | ICD-9-CM

### Language 2.16.840.1.113883.6.121

Language | Display Name | Description
--- | --- | ---
it-IT | Language | Language

## List of Template Identifiers used in this project

Id | Display Name | Effective date | Type
--- | --- | --- | ---
2.16.840.1.113883.10.12.151 | CDA Organization | 2005‑09‑07 | cdaheaderlevel cdaentrylevel
2.16.840.1.113883.10.12.152 | CDA Person | 2005‑09‑07 | cdaheaderlevel cdaentrylevel
2.16.840.1.113883.10.12.153 | CDA AssignedEntity | 2005‑09‑07 | cdaheaderlevel cdaentrylevel
2.16.840.1.113883.10.12.300 | CDA Clinical Statement | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.301 | CDA Act | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.302 | CDA Encounter | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.303 | CDA Observation | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.304 | CDA ObservationMedia | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.305 | CDA Organizer | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.306 | CDA Procedure | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.307 | CDA RegionOfInterest | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.308 | CDA SubstanceAdministration | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.309 | CDA Supply | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.310 | CDA LabeledDrug | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.311 | CDA Material | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.312 | CDA ManufacturedProduct | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.313 | CDA PlayingEntity | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.315 | CDA Device | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.316 | CDA RelatedEntity | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.318 | CDA Author (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.319 | CDA Informant (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.320 | CDA Subject (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.321 | CDA Participant (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.322 | CDA Specimen | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.323 | CDA Performer (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.324 | CDA Reference | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.325 | CDA ExternalAct | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.326 | CDA ExternalObservation | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.327 | CDA ExternalProcedure | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.328 | CDA ExternalDocument | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.329 | CDA Precondition | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.2.9.10.1.16.2.1 | Relazione collaborativa di Teleconsulto | 2026‑06‑04 11:54:27 | cdadocumentlevel
2.16.840.1.113883.2.9.10.1.6.53 | Codice Farmaco | 2018‑03‑19 | cdaentrylevel
hl7itig-template-1070 | Act_RichiestaTeleconsulto | 2026‑06‑09 12:21:01 | clinicalstatementlevel
hl7itig-template-1071 | Act prestazioni TeleConsulto | 2026‑06‑19 10:19:01 | cdaentrylevel
hl7itig-template-1072 | Prestazioni (TeleConsulto) | 2026‑06‑19 10:22:01 | cdasectionlevel
hl7itig-template-136 | Cronicità della patologia | 2022‑09‑21 15:09:38 | cdaentrylevel
hl7itig-template-137 | Stato clinico del problema | 2022‑09‑21 15:51:49 | cdaentrylevel
hl7itig-template-139 | Grado di parentela | 2022‑09‑21 16:30:55 | cdaentrylevel
hl7itig-template-144 | Dettaglio Anamnesi Familiare | 2022‑09‑21 17:31:26 | cdaentrylevel
hl7itig-template-145 | Età Insorgenza | 2022‑09‑21 18:02:11 | cdaentrylevel
hl7itig-template-152 | Età decesso | 2022‑09‑22 14:51:22 | cdaentrylevel
hl7itig-template-161 | Descrizione Agente | 2022‑09‑25 15:11:00 | cdaentrylevel
hl7itig-template-162 | playingEntity - Agente | 2022‑09‑25 15:14:41 | cdaentrylevel
hl7itig-template-163 | Descrizione Reazione | 2022‑09‑25 15:31:14 | cdaentrylevel
hl7itig-template-164 | Descrizione Criticità | 2022‑09‑25 15:49:29 | cdaentrylevel
hl7itig-template-165 | Stato dell'Allergia/Intolleranza | 2022‑09‑25 15:59:50 | cdaentrylevel
hl7itig-template-166 | Commenti | 2022‑09‑25 20:01:32 | cdaentrylevel
hl7itig-template-260 | custodianOrganization | 2022‑10‑11 09:38:33 | cdaheaderlevel cdaentrylevel
hl7itig-template-272 | MaintainedEntity | 2022‑12‑13 10:32:08 | cdaheaderlevel
hl7itig-template-34 | CDA addr | 2022‑07‑04 10:39:03 | cdaheaderlevel
hl7itig-template-35 | CDA assignedAuthoringDevice | 2022‑07‑04 10:43:40 | cdaheaderlevel
hl7itig-template-36 | CDA AssignedEntity | 2022‑07‑04 10:50:59 | cdaheaderlevel cdaentrylevel
hl7itig-template-374 | CDA Organization RSA | 2023‑12‑17 12:39:45 | cdaheaderlevel
hl7itig-template-396 | Observation Prestazioni | 2023‑12‑21 11:27:53 | notype
hl7itig-template-52 | CDA place (VPS) | 2022‑07‑04 14:59:35 | cdaheaderlevel
hl7itig-template-54 | CDA person | 2022‑07‑04 15:02:36 | cdaheaderlevel
hl7itig-template-58 | CDA Organization | 2022‑07‑04 15:12:59 | cdaheaderlevel
hl7itig-template-59 | CDA organizationPartOf | 2022‑07‑04 15:14:04 | cdaheaderlevel
hl7itig-template-60 | CDA name | 2022‑07‑04 15:16:59 | cdaheaderlevel
hl7itig-template-609 | CDA recordTargetTele | 2025‑05‑21 14:42:44 | cdaheaderlevel
hl7itig-template-610 | CDA addrTEL | 2025‑05‑21 14:47:14 | cdaheaderlevel
hl7itig-template-648 | Quesito Diagnostico (Tele) | 2025‑05‑27 12:28:52 | cdasectionlevel
hl7itig-template-649 | Storia Clinica (Tele) | 2025‑05‑27 12:31:35 | cdasectionlevel
hl7itig-template-650 | Anamnesi Fisiologica-Patologica (Tele) | 2025‑05‑27 12:33:41 | cdaentrylevel
hl7itig-template-651 | Anamnesi Familiare (Tele) | 2025‑05‑27 12:38:09 | cdaentrylevel
hl7itig-template-652 | Allergie (Tele) | 2025‑05‑27 12:41:38 | cdasectionlevel
hl7itig-template-653 | Terapia Farmacologica In Atto (Tele) | 2025‑05‑27 12:49:36 | cdasectionlevel
hl7itig-template-654 | CDA author teleCons | 2025‑05‑27 12:56:33 | cdaheaderlevel
hl7itig-template-655 | CDA Organization Tele | 2025‑05‑27 13:13:04 | cdaheaderlevel cdaentrylevel
hl7itig-template-656 | Precedenti Esami Eseguiti (Tele) | 2025‑05‑28 09:18:26 | cdasectionlevel
hl7itig-template-659 | Act Procedure Tele | 2025‑05‑28 09:57:04 | cdaentrylevel
hl7itig-template-660 | Participant Prestazione (Tele) | 2025‑05‑28 09:59:24 | notype
hl7itig-template-661 | Nota Prestazioni Tele | 2025‑05‑28 10:01:43 | clinicalstatementlevel
hl7itig-template-662 | Act substanceAdministration Tele | 2025‑05‑28 10:10:06 | clinicalstatementlevel
hl7itig-template-663 | Act observation Tele | 2025‑05‑28 10:13:09 | cdaentrylevel
hl7itig-template-664 | Act_act_Tele | 2025‑05‑28 10:19:02 | notype
hl7itig-template-669 | Esame Obiettivo (Tele) | 2025‑05‑28 16:30:32 | cdasectionlevel
hl7itig-template-683 | CDA dataEnterer Teleconsulto | 2025‑06‑05 11:26:25 | cdaheaderlevel
hl7itig-template-685 | CDA legalAuthenticator Teleconsulto | 2025‑06‑05 11:45:16 | cdaheaderlevel
hl7itig-template-686 | CDA participant Teleconsulto | 2025‑06‑05 11:49:18 | cdaheaderlevel
hl7itig-template-687 | CDA inFulfillmentOf Teleconsulto | 2025‑06‑05 11:52:59 | cdaheaderlevel
hl7itig-template-688 | CDA documentationOf Teleconsulto | 2025‑06‑05 11:58:42 | cdaheaderlevel
hl7itig-template-689 | CDA relatedDocument Teleconsulto | 2025‑06‑05 11:59:59 | cdaheaderlevel
hl7itig-template-691 | CDA AssignedEntity Teleconsulto | 2025‑06‑05 12:20:10 | cdaheaderlevel cdaentrylevel
hl7itig-template-694 | Confronto Con Precedenti Esami Eseguiti (Tele) | 2025‑06‑05 14:32:48 | cdasectionlevel
hl7itig-template-695 | Referto (Tele) | 2025‑06‑05 14:38:25 | cdasectionlevel
hl7itig-template-696 | Diagnosi (Tele) | 2025‑06‑05 14:43:30 | cdasectionlevel
hl7itig-template-698 | Conclusioni (Tele) | 2025‑06‑05 14:54:39 | cdasectionlevel
hl7itig-template-699 | Suggerimenti Per Il Medico Prescrittore (Tele) | 2025‑06‑06 11:38:59 | cdasectionlevel
hl7itig-template-701 | Accertamenti e Controlli Consigliati (Tele) | 2025‑06‑09 10:55:49 | cdasectionlevel
hl7itig-template-702 | Terapia Farmacologica Consigliata (Tele) | 2025‑06‑09 10:59:20 | cdasectionlevel
hl7itig-template-703 | Obs_BrancaSpecialita (Tele) | 2025‑06‑09 12:41:39 | clinicalstatementlevel
hl7itig-template-704 | Obs_DisciplinaSpecialita | 2025‑06‑10 14:16:58 | clinicalstatementlevel
hl7itig-template-705 | Observation Prestazioni (Tele) | 2025‑06‑10 14:26:24 | notype
hl7itig-template-711 | CDA componentOf TeleConsulto (newVersion) | 2025‑06‑17 18:44:24 | cdaheaderlevel
hl7itig-template-716 | Allergie - act (Tele) | 2025‑07‑11 10:39:50 | cdaentrylevel
hl7itig-template-717 | Allergie - observation (Tele) | 2025‑07‑11 10:56:11 | cdaentrylevel
hl7itig-template-718 | Terapie Farmacologiche_SubstanceAdministration (Tele) | 2025‑07‑11 12:13:08 | cdaentrylevel
hl7itig-template-727 | observationMedia (Tele) | 2025‑07‑15 14:33:18 | notype
hl7itig-template-747 | CDA AddressBirthPlaceTele | 2025‑07‑24 17:24:14 | cdaheaderlevel
hl7itig-template-75 | CDA assignedCustodian | 2022‑07‑07 13:20:20 | cdaheaderlevel
hl7itig-template-768 | CDA custodian Tele | 2025‑09‑16 11:26:44 | cdaheaderlevel
hl7itig-template-789 | Participant Esecutore (Tele) | 2025‑09‑29 11:09:43 | cdaentrylevel
hl7itig-template-892 | CDA addr v1.0 | 2025‑12‑18 11:17:45 | cdaheaderlevel

## List of Value Set Identifiers used in this project

Id | Display Name | Effective date
--- | --- | ---
2.16.840.1.113883.1.11.13955 | ActEncounterCode | 2017‑12‑17
2.16.840.1.113883.1.11.16866 | ActPriority | 2022‑12‑22
2.16.840.1.113883.1.11.15933 | ActStatus | 2014‑03‑26
hl7itig-valueset-10 | X_ActStatusActiveSuspendedAbortedCompleted | 2022‑09‑25 13:39:28
2.16.840.1.113883.1.11.19708 | ActSubstanceAdministrationCode | 2014‑03‑26
2.16.840.1.113883.5.1119 | AddressUse | 2022‑11‑10
2.16.840.1.113883.1.11.14570 | AdministrableDrugForm | 2014‑03‑26
2.16.840.1.113883.1.11.1 | AdministrativeGender | 2014‑03‑26
hl7itig-valueset-56 | AllergenNoDrugs_PSSIT | 2024‑03‑14 11:43:25
2.16.840.1.113883.1.11.16040 | EntityCode | 2014‑03‑26
2.16.840.1.113883.2.9.5.1.4 | Estensione Vocabolario ActCode | 2023‑12‑15 16:36:19
2.16.840.1.113883.1.11.11526 | HumanLanguage | 2014‑03‑26
2.16.840.1.113883.1.11.16041 | MaterialEntityClassType | 2014‑03‑26
2.16.840.1.113883.1.11.78 | ObservationInterpretation | 2017‑12‑17
2.16.840.1.113883.1.11.14079 | ObservationMethod | 2014‑03‑26
2.16.840.1.113883.1.11.16226 | ObservationType | 2017‑12‑17
2.16.840.1.113883.1.11.10267 | ParticipationFunction | 2014‑03‑26
2.16.840.1.113883.1.11.16543 | ParticipationMode | 2014‑03‑26
2.16.840.1.113883.1.11.10901 | ParticipationType | 2014‑03‑26
2.16.840.1.113883.1.11.19563 | PersonalRelationshipRoleType | 2014‑03‑26
hl7itig-valueset-41 | ProblemCronicity_PSSIT | 2024‑02‑13 09:39:16
hl7itig-valueset-53 | ProblemObservation_PSSIT | 2024‑02‑28 12:03:14
2.16.840.1.113883.1.11.16117 | ROIOverlayShape | 2014‑03‑26
2.16.840.1.113883.1.11.19313 | RoleClassAssociative | 2014‑03‑26
2.16.840.1.113883.1.11.19316 | RoleClassMutualRelationship | 2014‑03‑26
2.16.840.1.113883.1.11.15999 | RoleStatus | 2014‑03‑26
2.16.840.1.113883.1.11.14581 | RouteOfAdministration | 2014‑03‑26
2.16.840.1.113883.1.11.17660 | ServiceDeliveryLocationRoleType | 2014‑03‑26
hl7itig-valueset-55 | StatoClinicoProblema_PSSIT | 2024‑03‑12 15:54:58
2.16.840.1.113883.1.11.10310 | TargetAwareness | 2014‑03‑26
2.16.840.1.113883.1.11.19599 | x_ActClassDocumentEntryAct | 2016‑11‑26
2.16.840.1.113883.1.11.19598 | x_ActClassDocumentEntryOrganizer | 2014‑03‑26
2.16.840.1.113883.1.11.18943 | x_ActMoodDocumentObservation | 2016‑11‑26
2.16.840.1.113883.1.11.11610 | x_ActRelationshipDocument | 2014‑03‑26
2.16.840.1.113883.1.11.19446 | x_ActRelationshipEntry | 2014‑03‑26
2.16.840.1.113883.1.11.19447 | x_ActRelationshipEntryRelationship | 2014‑03‑26
2.16.840.1.113883.1.11.19000 | x_ActRelationshipExternalReference | 2014‑03‑26
2.16.840.1.113883.1.11.16926 | x_BasicConfidentialityKind | 2014‑03‑26
2.16.840.1.113883.1.11.19458 | x_DocumentActMood | 2016‑11‑26
2.16.840.1.113883.1.11.19459 | x_DocumentEncounterMood | 2016‑11‑26
2.16.840.1.113883.1.11.19460 | x_DocumentProcedureMood | 2014‑03‑26
2.16.840.1.113883.1.11.19368 | x_DocumentSubject | 2014‑03‑26
2.16.840.1.113883.1.11.19461 | x_DocumentSubstanceMood | 2016‑11‑26

Datasets, codes, OIDs and Rules: this information is used for rendering and validation purposes.